Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001711279-21-000031
Filing Date
2021-11-08
Accepted
2021-11-08 07:10:01
Documents
59
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q krys-20210930.htm   iXBRL 10-Q 1371796
2 EX-31.1 krys-20210930ex3111.htm EX-31.1 10789
3 EX-31.2 krys-20210930ex3121.htm EX-31.2 10752
4 EX-32.1 krys-20210930ex3211.htm EX-32.1 11273
10 GRAPHIC krys-20210930_g1.jpg GRAPHIC 716546
  Complete submission text file 0001711279-21-000031.txt   7354084

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krys-20210930.xsd EX-101.SCH 35879
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT krys-20210930_cal.xml EX-101.CAL 55149
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT krys-20210930_def.xml EX-101.DEF 137355
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krys-20210930_lab.xml EX-101.LAB 462911
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krys-20210930_pre.xml EX-101.PRE 293508
11 EXTRACTED XBRL INSTANCE DOCUMENT krys-20210930_htm.xml XML 968376
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

EIN.: 821080209 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38210 | Film No.: 211386502
SIC: 2836 Biological Products, (No Diagnostic Substances)